INCYTE CORPORATION Number of Reportable Segments
INCYTE CORPORATION (INCY) reported Number of Reportable Segments of 1 segment for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-28.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-04-28
- INCYTE CORPORATION number of reportable segments for the quarter ending 2026-03-31 was 1.00 segment, a 0.00% change year-over-year.
- INCYTE CORPORATION number of reportable segments for the quarter ending 2025-03-31 was 1.00 segment.
- INCYTE CORPORATION number of reportable segments for fiscal 2025 was 1.00 segment, a 0.00% change from fiscal 2024.
- INCYTE CORPORATION number of reportable segments for fiscal 2024 was 1.00 segment.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-10 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-29 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |